Tech Company Financing Transactions

Ossium Health Funding Round

Ossium Health secured a $52 million Series C financing round on 7/25/2023. Investors included CPMG, Alumni Ventures and First Round Capital.

Transaction Overview

Company Name
Announced On
7/25/2023
Transaction Type
Venture Equity
Amount
$52,000,000
Round
Series C
Proceeds Purpose
The company will deploy this funding to grow its proprietary bone marrow bank, build on existing clinical trials, and accelerate new product development. This round will also support the launch of Ossigraft�, an orthopedic product for the repair, replacement, and reconstruction of musculoskeletal defects. This product is derived from the same vertebral bodies as Ossium's other products, and provides another opportunity to honor the precious gift of donated tissue. This product is slated to enter the clinic in the second half of 2023.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5742 W 74th St.
Indianapolis, IN 46278
USA
Email Address
Overview
Ossium's mission is to improve human health. We will deploy cellular therapeutics, bioengineering, and other regenerative medical tools to produce lasting gains in the health, vitality, and longevity of human beings. In pursuit of these goals, we will foster a culture that empowers our stakeholders, maintain the highest standards of operational excellence.
Profile
Ossium Health LinkedIn Company Profile
Social Media
Ossium Health Company Twitter Account
Company News
Ossium Health News
Facebook
Ossium Health on Facebook
YouTube
Ossium Health on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Kevin Caldwell
  Kevin Caldwell LinkedIn Profile  Kevin Caldwell Twitter Account  Kevin Caldwell News  Kevin Caldwell on Facebook
Chief Medical Officer
Scott Goebel
  Scott Goebel LinkedIn Profile  Scott Goebel Twitter Account  Scott Goebel News  Scott Goebel on Facebook
Chief Scientific Officer
Erik Woods
  Erik Woods LinkedIn Profile  Erik Woods Twitter Account  Erik Woods News  Erik Woods on Facebook
VP - Human Resources
Jay Gardner
  Jay Gardner LinkedIn Profile  Jay Gardner Twitter Account  Jay Gardner News  Jay Gardner on Facebook
VP - Operations
Margie Mathewson
  Margie Mathewson LinkedIn Profile  Margie Mathewson Twitter Account  Margie Mathewson News  Margie Mathewson on Facebook
VP - R & D
Brian Johnstone
  Brian Johnstone LinkedIn Profile  Brian Johnstone Twitter Account  Brian Johnstone News  Brian Johnstone on Facebook
VP - Regulatory Affairs
Oliver Cacananta
  Oliver Cacananta LinkedIn Profile  Oliver Cacananta Twitter Account  Oliver Cacananta News  Oliver Cacananta on Facebook
VP - Regulatory Affairs
Jonathon Rochelle
  Jonathon Rochelle LinkedIn Profile  Jonathon Rochelle Twitter Account  Jonathon Rochelle News  Jonathon Rochelle on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/25/2023: ETCH venture capital transaction
Next: 7/25/2023: Space DOTS venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary